Company Number: SC710905

Analysis Date: 2025-07-29 19:34 UTC

Financial Health Assessment: AGGLETON ENTERPRISES LTD (Year ended 31 March 2024)

---

1. Financial Health Score: C

Explanation:
Aggleton Enterprises Ltd shows a moderately stable financial position with positive net assets and shareholders’ funds, but exhibits symptoms of liquidity strain and working capital challenges. The company is asset-heavy with significant fixed assets but lacks sufficient current assets to cover short-term liabilities, indicating potential cash flow stress. The score reflects a company that is solvent but must manage its liquidity carefully to ensure ongoing financial wellness.

---

2. Key Vital Signs

Metric	2024 (£)	Interpretation
Fixed Assets	2,555,194	Strong asset base, likely property or investments; “healthy skeleton” of company worth.
Current Assets	0	No liquid or short-term assets available; red flag for immediate liquidity needs.
Current Liabilities	1,899,157	High short-term obligations; “pressing debts due soon.”
Net Current Assets (Working Capital)	-268,707	Negative working capital; “symptom of short-term financial distress.”
Total Liabilities (Current + Long-term)	~3.8 million	Substantial overall debt load relative to assets.
Net Assets / Shareholders Funds	387,430	Equity positive and improving year-on-year; “sign of solvency.”
Change in Net Assets (2023 to 2024)	+153,465	Improvement in net worth indicates partial recovery/retained profits.

Additional Notes:

• No employees currently, indicating a non-operational or holding structure.
• Micro-entity reporting status limits detailed disclosures but indicates small scale.
• Directors are family members with significant control, suggesting closely held ownership.

---

3. Diagnosis: Financial Health Overview

Aggleton Enterprises Ltd operates primarily as a holding company (SIC 64209), with significant fixed assets likely representing investment properties or subsidiaries. The company’s financial "vitals" reveal a sturdy asset base but poor liquidity, as current assets are nil, while current liabilities remain high. This creates a working capital deficit, a classic symptom of short-term cash flow stress.

The positive net assets and improving equity reflect that the business remains solvent and has navigated previous years' losses (negative net assets in 2021). This suggests that while the company carries heavy obligations, these are backed by long-term assets, providing a buffer against insolvency risk.

However, the absence of liquid assets means the company may struggle to meet immediate obligations without refinancing or asset sales. The lack of employees and operating income further indicates reliance on investments or external capital flows for sustainability.

In medical terms, the company’s "heart" (equity and fixed assets) is strong, but its "circulatory system" (liquidity and cash flow) is compromised, requiring intervention to prevent financial distress.

---

4. Recommendations: Path to Financial Wellness

• Improve Liquidity:
  Explore ways to increase current assets—consider converting fixed assets to cash or securing short-term financing to cover liabilities and ease working capital strain. A “healthy cash flow” is vital to avoid default risks.

• Debt Management:
  Review and renegotiate terms of current liabilities, particularly those falling due within one year, to extend payment periods or reduce interest burdens.

• Operational Review:
  Although the company is a holding entity, evaluate the performance and dividend policies of subsidiaries or investments to ensure steady income streams.

• Financial Planning:
  Develop cash flow forecasts and stress tests to anticipate liquidity crunches and plan mitigating actions proactively.

• Governance and Oversight:
  Given the family-director structure, implement formal financial controls and independent reviews to ensure transparency and robust decision-making.

• Consider Strategic Asset Sales:
  If liquidity remains an issue, selectively dispose of non-core fixed assets to bolster cash reserves.

---